{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T02:02:57Z","timestamp":1771552977746,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Parkinson's UK"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-026-09529-2","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T09:50:45Z","timestamp":1771321845000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Public involvement in the design of a complex neurosurgical clinical trial (the GDNF trial) and an associated support package: reflections and recommendations"],"prefix":"10.1186","volume":"27","author":[{"given":"Nikul","family":"Bakshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Bale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tincy","family":"Binu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayne","family":"Calder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesley","family":"Gosden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Phipps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4908-1951","authenticated-orcid":false,"given":"Richard","family":"Prettyman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur","family":"Roach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2184-4865","authenticated-orcid":false,"given":"Danielle H.","family":"Bodicoat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8931-4422","authenticated-orcid":false,"given":"Alan","family":"Whone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"issue":"10291","key":"9529_CR1","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. Lancet. 2021;397(10291):2284\u2013303.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"9529_CR2","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.1016\/j.parkreldis.2015.09.004","volume":"22","author":"RF Pfeiffer","year":"2016","unstructured":"Pfeiffer RF. Non-motor symptoms in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2016;22(Suppl 1):S119-22.","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"9529_CR3","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/1531-8257(200011)15:6<1112::AID-MDS1008>3.0.CO;2-A","volume":"15","author":"A Schrag","year":"2000","unstructured":"Schrag A, Jahanshahi M, Quinn N. How does Parkinson\u2019s disease affect quality of life? A comparison with quality of life in the general population. Mov Disord. 2000;15(6):1112\u20138.","journal-title":"Mov Disord"},{"issue":"8","key":"9529_CR4","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","volume":"124","author":"OB Tysnes","year":"2017","unstructured":"Tysnes OB, Storstein A. Epidemiology of Parkinson\u2019s disease. J Neural Transm. 2017;124(8):901\u20135.","journal-title":"J Neural Transm"},{"issue":"11","key":"9529_CR5","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"Collaborators, G.P.s.D.","year":"2018","unstructured":"Collaborators, G.P.s.D. Global, regional, and national burden of Parkinson\u2019s disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):939\u201353.","journal-title":"Lancet Neurol"},{"issue":"4","key":"9529_CR6","doi-asserted-by":"publisher","first-page":"393","DOI":"10.7861\/clinmed.2020-0220","volume":"20","author":"C Kobylecki","year":"2020","unstructured":"Kobylecki C. Update on the diagnosis and management of Parkinson\u2019s disease. Clin Med (Lond). 2020;20(4):393\u20138.","journal-title":"Clin Med (Lond)"},{"issue":"5","key":"9529_CR7","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s13311-022-01292-x","volume":"19","author":"LB Reoma","year":"2022","unstructured":"Reoma LB, Karp BI. The human cost: patient contribution to clinical trials in neurology. Neurotherapeutics. 2022;19(5):1503\u20136.","journal-title":"Neurotherapeutics"},{"issue":"6","key":"9529_CR8","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/cts.12297","volume":"8","author":"EM Cobb","year":"2015","unstructured":"Cobb EM, et al. Patient engagement in neurological clinical trials design: a conference summary. Clin Transl Sci. 2015;8(6):776\u20138.","journal-title":"Clin Transl Sci"},{"issue":"1","key":"9529_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s40900-024-00649-0","volume":"10","author":"O MacCormac","year":"2024","unstructured":"MacCormac O, et al. Science for tomorrow\u2019s neurosurgery: insights on establishing a neurosurgery patient group focused on developing novel intra-operative imaging techniques. Res Involv Engagem. 2024;10(1):112.","journal-title":"Res Involv Engagem"},{"key":"9529_CR10","unstructured":"UK Public Involvement Standards Development Partnership. UK Standards for Public Involvement. 2016 [cited 2025 28\/02\/2025]; Available from: https:\/\/sites.google.com\/nihr.ac.uk\/pi-standards\/about-us."},{"issue":"3","key":"9529_CR11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.4103\/jpgm.jpgm_83_23","volume":"69","author":"ZM Mojadeddi","year":"2023","unstructured":"Mojadeddi ZM, \u00d6berg S, Rosenberg J. Low degree of patient involvement in contemporary surgical research: a scoping review. J Postgrad Med. 2023;69(3):153\u20138.","journal-title":"J Postgrad Med"},{"issue":"3","key":"9529_CR12","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/brain\/awz023","volume":"142","author":"A Whone","year":"2019","unstructured":"Whone A, et al. Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson\u2019s disease. Brain. 2019;142(3):512\u201325.","journal-title":"Brain"},{"issue":"3","key":"9529_CR13","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3233\/JPD-202004","volume":"10","author":"RA Barker","year":"2020","unstructured":"Barker RA, et al. GDNF and Parkinson\u2019s disease: where next? A summary from a recent workshop. J Parkinsons Dis. 2020;10(3):875\u201391.","journal-title":"J Parkinsons Dis"},{"key":"9529_CR14","unstructured":"Parkinson\u2019s UK. An update on GDNF trials for Parkinson\u2019s. 2024 [cited 2025 11\/02\/2025]; Available from: https:\/\/www.parkinsons.org.uk\/news\/update-gdnf-trials-parkinsons."},{"key":"9529_CR15","volume-title":"Public Involvement in Research Impact Toolkit (PIRIT)","author":"A Newman","year":"2023","unstructured":"Newman A. Public Involvement in Research Impact Toolkit (PIRIT). Wales, UK: Cardiff University; 2023."},{"issue":"1","key":"9529_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/hsc.13111","volume":"29","author":"MSY Biddle","year":"2021","unstructured":"Biddle MSY, Gibson A, Evans D. Attitudes and approaches to patient and public involvement across Europe: a systematic review. Health Soc Care Community. 2021;29(1):18\u201327.","journal-title":"Health Soc Care Community"},{"key":"9529_CR17","unstructured":"NHS Health Research Authority. Public involvement. 2025 [cited 2025 17\/02\/2025]; Available from: https:\/\/www.hra.nhs.uk\/planning-and-improving-research\/best-practice\/public-involvement\/."},{"issue":"1","key":"9529_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s40900-024-00572-4","volume":"10","author":"WJ Cragg","year":"2024","unstructured":"Cragg WJ, et al. How can we support research participants who stop taking part? Communications guidance developed through public-researcher collaboration. Res Involv Engagem. 2024;10(1):39.","journal-title":"Res Involv Engagem"},{"key":"9529_CR19","unstructured":"mdgroup. The importance of looking after a patient\u2019s mental health during clinical trials. 2020 [cited 2025 06\/04\/2025]; Available from: https:\/\/mdgroup.com\/blog\/the-importance-of-looking-after-a-patients-mental-health-during-clinical-trials\/."},{"key":"9529_CR20","unstructured":"Cuttsy & Cuttsy. Caring for patients\u2019 mental health in clinical trials. 2024 [cited 2025 06\/04\/2025]; Available from: https:\/\/www.cuttsyandcuttsy.com\/latest\/caring-for-patients-mental-health-in-clinical-trials."},{"issue":"6","key":"9529_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361\u201370.","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"9529_CR22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1017\/S0033291700021644","volume":"9","author":"DP Goldberg","year":"1979","unstructured":"Goldberg DP, Hillier VF. A scaled version of the General Health Questionnaire. Psychol Med. 1979;9(1):139\u201345.","journal-title":"Psychol Med"},{"key":"9529_CR23","unstructured":"Rare Disease Research Partners. Counselling for clinical trial participants. 2025 [cited 2025 06\/04\/2025]; Available from: https:\/\/www.rd-rp.com\/counselling-support-for-clinical-trial-participants."},{"issue":"11","key":"9529_CR24","volume":"16","author":"KM Frasier","year":"2024","unstructured":"Frasier KM, et al. The psychology behind the efficacy of a buddy system for enhancing retention in dermatological clinical trials. Cureus. 2024;16(11):e72986.","journal-title":"Cureus"},{"key":"9529_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph191912041","author":"S Addison","year":"2022","unstructured":"Addison S, et al. The role of social support in cardiovascular clinical trial participation among black men: black impact. Int J Environ Res Public Health. 2022. https:\/\/doi.org\/10.3390\/ijerph191912041.","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"9529_CR26","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1136\/jme-2023-109719","volume":"51","author":"A Harris","year":"2025","unstructured":"Harris A, Gilbert F. Need for greater post-trial support for clinical trial participants assessing high-risk, irreversible treatments. J Med Ethics. 2025;51(4):268\u201373.","journal-title":"J Med Ethics"},{"issue":"1","key":"9529_CR27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13063-018-2535-5","volume":"19","author":"S Treweek","year":"2018","unstructured":"Treweek S, et al. Trial forge guidance 1: what is a study within a trial (SWAT)? Trials. 2018;19(1):139.","journal-title":"Trials"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-026-09529-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09529-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09529-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T01:06:39Z","timestamp":1771549599000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-026-09529-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9529"],"URL":"https:\/\/doi.org\/10.1186\/s13063-026-09529-2","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"27 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was not obtained as this was a PPI project, rather than a research study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"NB, CB, and AR are employees of Parkinson\u2019s UK. NB is a Board member of Patient Focused Medicines Development. CB is a Board member of Parkinson\u2019s Europe. DB has received consulting fees from Parkinson\u2019s UK, University of Leicester, Lindus Health, and HEOR Value Hub. LG has received payment or honoraria for presenting from Britannia Pharmaceuticals and is an Advisory Board member for Parexel MMS Europe Limited. AR is a Director of Vivifi Biotech Limited. AW has received consulting fees from AskBio. The other authors have declared no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"158"}}